What steps are needed to enable wider adoption of process intensification in biopharma? 31-Aug-2022 By Jane Byrne Process intensification is the natural next step for the biopharma industry as it transitions from a focus on global blockbuster drugs to a diversified portfolio of specialized biopharmaceuticals, finds a study.
